SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-007848
Filing Date
2020-05-06
Accepted
2020-05-06 17:07:58
Documents
6
Period of Report
2020-04-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 47537
2 ex3-1.htm EX-3.1 8556
3 ex99-1.htm EX-99.1 153022
4 ex99-2.htm EX-99.2 26483
5 ex99-7.htm EX-99.7 9451
6 ex99-2_001.jpg GRAPHIC 6844
  Complete submission text file 0001493152-20-007848.txt   256101
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 20853536
SIC: 2834 Pharmaceutical Preparations